Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.22 USD | +3.23% | +4.91% | -19.06% |
Financials (USD)
Sales 2024 * | 632M | Sales 2025 * | 708M | Capitalization | 2.64B |
---|---|---|---|---|---|
Net income 2024 * | 109M | Net income 2025 * | 148M | EV / Sales 2024 * | 3.14 x |
Net cash position 2024 * | 659M | Net cash position 2025 * | 748M | EV / Sales 2025 * | 2.68 x |
P/E ratio 2024 * |
26.4
x | P/E ratio 2025 * |
19.8
x | Employees | 352 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.18% |
Latest transcript on Corcept Therapeutics Incorporated
1 day | +3.76% | ||
1 week | +6.37% | ||
Current month | +8.92% | ||
1 month | +4.83% | ||
3 months | +12.94% | ||
6 months | -1.40% | ||
Current year | -21.80% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 98-05-12 |
Atabak Mokari
DFI | Director of Finance/CFO | 47 | 21-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 98-05-12 |
Gregg Alton
BRD | Director/Board Member | 58 | 20-03-11 |
George Baker
BRD | Director/Board Member | 81 | 98-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.71% | 0 M€ | -2.03% | ||
0.30% | 0 M€ | +2.66% | ||
0.27% | 0 M€ | -3.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 26.22 | +3.23% | 570 532 |
24-05-08 | 25.4 | +3.76% | 932,703 |
24-05-07 | 24.48 | +2.13% | 876,430 |
24-05-06 | 23.97 | -2.24% | 1,230,562 |
24-05-03 | 24.52 | -2.15% | 1,698,297 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.80% | 2.64B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.70% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- CORT Stock